New Delhi, Feb 12: Sarvagun, a modern Ayurveda and holistic healthcare brand backed by RASA Group, is witnessing rapid growth as demand rises for personalized, preventive healthcare solutions in India. The brand has served over 2,000 patients across its centres to date and is recording a month-on-month growth of 35%, positioning it to achieve an annual recurring revenue (ARR) of ₹10–12 crore over the next 12 months.

As consumer preferences shift toward preventive and holistic healthcare, Sarvagun is working to professionalize and scale Ayurveda by introducing measurable outcomes, consistent care pathways, and data-informed personalization bridging the gap between traditional medicine and contemporary healthcare delivery.

Commenting on the brand’s growth, Rahul Agarwal, Founder, RASA Group, said: “Sarvagun was created to make Ayurveda more relevant and accountable for today’s consumers. By focusing on outcomes, personalization, and root-cause treatment, the brand is building a scalable healthcare model that goes beyond symptomatic relief. The strong patient traction and steady growth reinforce our belief in this approach.”

Built on the philosophy of combining classical Ayurvedic science with modern, standardized treatment protocols, Sarvagun focuses on structured, outcome-driven, and root-cause-based healing. Its offerings include personalized treatment plans, Panchakarma detox therapies, nutritional guidance, and integrated wellness practices such as yoga and meditation, aimed at managing lifestyle and chronic health conditions through long-term care.

Looking ahead, RASA Group plans to scale Sarvagun pan-India over the next three to five years, with ambitions to build a nationally recognized healthcare platform. The Group is also evaluating a potential listing of RASA Group or one of its sub-brands within the next two to three years, as it continues to deepen its footprint in India’s rapidly evolving healthcare and wellness ecosystem.